IRIS
MARCHI, SERENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.860
NA - Nord America 1.480
AS - Asia 301
AF - Africa 39
SA - Sud America 6
OC - Oceania 2
Totale 4.688
Salva come PNG Salva come JPEG
Nazione #
GB - Regno Unito 1.539
US - Stati Uniti d'America 1.473
IT - Italia 425
IE - Irlanda 356
RU - Federazione Russa 190
SG - Singapore 122
SE - Svezia 104
CN - Cina 81
FR - Francia 72
VN - Vietnam 67
DE - Germania 55
UA - Ucraina 43
FI - Finlandia 28
CI - Costa d'Avorio 27
BE - Belgio 10
TR - Turchia 10
IN - India 8
ES - Italia 7
NL - Olanda 6
CA - Canada 5
LT - Lituania 5
AT - Austria 4
NG - Nigeria 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
GM - Gambi 3
HK - Hong Kong 3
IR - Iran 3
PH - Filippine 3
AU - Australia 2
GH - Ghana 2
PE - Perù 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BR - Brasile 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
NO - Norvegia 1
PA - Panama 1
RO - Romania 1
TJ - Tagikistan 1
ZA - Sudafrica 1
Totale 4.688
Salva come PNG Salva come JPEG
Città #
Southend 1.513
Dublin 351
Santa Clara 253
Chandler 174
Fairfield 161
Siena 153
Singapore 97
Ashburn 96
Woodbridge 95
Seattle 67
Dong Ket 66
Houston 64
Wilmington 61
Cambridge 54
Princeton 40
Ann Arbor 38
Jacksonville 36
Abidjan 27
Florence 26
San Diego 24
Munich 23
Rome 21
Shanghai 21
Beijing 19
Helsinki 19
San Mateo 19
Milan 16
Moscow 14
Livorno 12
New York 11
Baltimore 9
Boardman 9
Brussels 9
Dearborn 8
Nanjing 8
Redwood City 8
Lappeenranta 7
Málaga 7
Bari 5
Bologna 5
Fremont 5
Guangzhou 5
Izmir 5
Abuja 4
Brescia 4
Cagliari 4
Carmignano 4
Chicago 4
Roccagorga 4
Teramo 4
Vienna 4
Andover 3
Arezzo 3
Banjul 3
Dallas 3
Frankfurt am Main 3
Gattatico 3
Greenwich 3
Leawood 3
London 3
Los Angeles 3
Mersin 3
Newark 3
Norwalk 3
Padova 3
Perugia 3
Pisa 3
San Francisco 3
St Petersburg 3
Toronto 3
Torre Del Greco 3
Verona 3
Alba 2
Aversa 2
Bangalore 2
Bibbiena 2
Briey 2
Brno 2
Castelfranco Di Sotto 2
Certaldo 2
Chatham 2
Colle di Val d'Elsa 2
Corinaldo 2
Falkenstein 2
Gallarate 2
Henderson 2
Hong Kong 2
Hounslow 2
Jinan 2
Koforidua 2
Lima 2
Manila 2
Misterbianco 2
Nanchang 2
Paris 2
Pescara 2
Radda in Chianti 2
San Donaci 2
Sansepolcro 2
Santa Croce sull'Arno 2
Totale 3.812
Salva come PNG Salva come JPEG
Nome #
Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014 473
Toxoplasma gondii in women of childbearing age and during pregnancy: seroprevalence study in Central and Southern Italy from 2013 to 2017 407
Elimination of congenital rubella: a seroprevalence study of pregnant women and women of childbearing age in Italy 399
Pertussis over two decades: Seroepidemiological study in a large population of the Siena Province, Tuscany Region, Central Italy 356
Influenza D virus: Serological evidence in the Italian population from 2005 to 2017 169
Challenges in the development of egg-independent vaccines for influenza 161
Impact of erythrocyte species on assays for influenza serology 150
null 136
System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2 134
Exploring the implication of DDX3X in DENV infection: discovery of the first-in-class DDX3X fluorescent inhibitor 132
Measles in pregnancy: a threat for Italian women? 130
Surveillance for severe acute respiratory infections among hospitalized subjects from 2015/2016 to 2019/2020 seasons in Tuscany, Italy 120
Evaluation of SARS‐CoV‐2 neutralizing antibodies using a CPE‐based colorimetric live virus micro‐neutralization assay in human serum samples 115
Immunity to measles in Italian children and adolescents: a persistent problem in view of measles elimination 113
Serologically-Based Evaluation of Cross-Protection Antibody Responses among Different A(H1N1) Influenza Strains 109
Low prevalence of antibodies against pertussis in pregnant women in Italy 108
Zika virus in west africa: A seroepidemiological study between 2007 and 2012 101
Seroepidemiological study of Zika virus in selected West African countries between 2007 and 2012 87
Evaluation of varicella immunity during pregnancy in apulia region, southern italy 87
Emerging and Re-emerging Arboviral Diseases as a Global Health Problem 83
A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019? 77
Measles Susceptibility in Apulia: The Italian Mirror? 73
SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy 67
Serum neutralizing activity against b.1.1.7, b.1.351, and p.1 sars-cov-2 variants of concern in hospitalized covid-19 patients 66
Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage 63
SARS-CoV-2 epidemiological trend before vaccination era: a seroprevalence study in Apulia, Southern Italy, in 2020 52
Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations 48
Evaluation of Monkeypox- and Vaccinia virus-neutralizing antibodies in human serum samples after vaccination and natural infection 46
Seroprevalence study of Toscana virus and viruses belonging to the Sandfly fever Naples antigenic complex in central and southern Italy 43
Detection of IgM, IgG and SARS-CoV-2 RNA among the personnel of the University of Milan, March through May 2020: The UNICORN study 40
Establishment and validation of a high-throughput micro-neutralization assay for respiratory syncytial virus (subtypes A and B) 39
Detection of antibodies against influenza D virus in swine veterinarians in Italy in 2004 37
Measles immunity over two decades in two large Italian Regions: How far is the elimination goal? 34
West Nile Virus Seroprevalence in the Italian Tuscany Region from 2016 to 2019 33
Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection 32
COVID-19 Outbreak and BNT162b2 mRNA Vaccination Coverage in a Correctional Facility during Circulation of the SARS-CoV-2 Omicron BA.1 Variant in Italy 32
Immunogenicity of Calvenza-03 EIV/EHV® Vaccine in Horses: Comparative In Vivo Study 31
The burden of influenza and the role of influenza vaccination in adults aged 50-64 years: A summary of available evidence 31
SARS-CoV-2 and influenza virus coinfections in the Tuscan population during the 2021/2022 influenza season 29
Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples 28
In vitro virucidal activity of mouthwashes on SARS-CoV-2 27
Evaluation of immune response to SARS-CoV-2 Omicron sublineages six months after different vaccination regimens in Italy 26
Improving the ONE HEALTH approach: a lesson from SARS-CoV-2 pandemic 25
Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study 24
An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study 24
Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy 23
Seroprevalence of antibodies to cytomegalovirus in pregnant women in the Apulia region (Italy) 23
Evaluation of monkeypox‐ and vaccinia‐virus neutralizing antibodies before and after smallpox vaccination: A sero‐epidemiological study 21
Serological Evidence for Circulation of Influenza D Virus in the Ovine Population in Italy 20
Viricide activity of antimicrobial blue light (405 nm) against the SARS-CoV-2 and influenza virus 18
Detection of Influenza D Antibodies in Dogs, Apulia Region, Italy, 2016 and 2023 18
Seroprotection against tetanus in the Italian general population 17
Evaluation of antibody response to SARS-CoV-2 variants after 2 doses of mRNA COVID-19 vaccine in a correctional facility 17
Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination 16
Centenarians, semi and supercentenarians, COVID-19 and Spanish flu: a serological assessment to gain insight into the resilience of older centenarians to COVID-19 16
The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees 16
Effects of Influenza Vaccine on the Immune Responses to SARS-CoV-2 Vaccination 15
Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines 14
Prevalence of Influenza B/Yamagata Viruses From Season 2012/2013 to 2021/2022 in Italy as an Indication of a Potential Lineage Extinction 14
Serological follow-up of SARS-CoV-2 asymptomatic subjects 14
The baculovirus expression vector system: a modern technology for the future of influenza vaccine manufacturing 13
Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study 11
Flu vaccine administration in the period before SARS-CoV-2 infection and its outcomes: An umbrella review 11
High Seroprevalence of Chikungunya Virus Antibodies Among Pregnant Women Living in an Urban Area in Benin, West Africa 11
SARS-CoV-2 Circulation during the First Year of the Pandemic: A Seroprevalence Study from January to December 2020 in Tuscany, Italy 9
Influenza D Virus: A Potential Threat for Humans? 9
Seroprevalence of measles antibodies in the Italian general population in 2019–2020 8
Zika Virus Epidemiology in Selected West African Countries between 2007 and 2012 7
Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection 7
Serum neutralizing activity against SARS-CoV-2 variants in hospitalized COVID-19 patients 6
Totale 4.951
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.744
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.744
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020574 0 0 0 0 0 44 73 84 100 92 84 97
2020/20211.335 65 89 63 171 174 119 76 116 98 117 105 142
2021/2022596 80 95 88 46 19 24 23 22 35 32 50 82
2022/2023559 32 80 65 64 44 93 26 49 68 14 17 7
2023/2024651 17 27 59 24 17 134 249 21 10 34 7 52
2024/2025995 37 175 198 164 246 175 0 0 0 0 0 0
Totale 4.951